Curis
CRIS
#10981
Rank
C$0.95 M
Marketcap
C$0.49
Share price
-17.89%
Change (1 day)
-79.49%
Change (1 year)

Curis (CRIS) - Total debt

Total debt on the balance sheet as of September 2025 : C$2.77 Million

According to Curis's latest financial reports the company's total debt is C$2.77 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Curis - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$4.23 M14.39%
2023-12-31C$3.7 M-30.7%
2022-12-31C$5.34 M-16.74%
2021-12-31C$6.42 M-34.25%
2020-12-31C$9.76 M4406.14%
2019-12-31C$0.21 M-99.55%
2018-12-31C$48.33 M-7.48%
2017-12-31C$52.24 M95.76%
2016-12-31C$26.68 M-20.38%
2015-12-31C$33.52 M2.07%
2014-12-31C$32.84 M0.97%
2013-12-31C$32.52 M9.62%
2012-12-31C$29.67 M
2008-12-31N/A-100%
2007-12-31C$0.4 M-82.52%
2006-12-31C$2.3 M-66.05%
2005-12-31C$6.78 M-17.49%
2004-12-31C$8.22 M12.15%
2003-12-31C$7.33 M-62.58%
2002-12-31C$19.6 M16.47%
2001-12-31C$16.83 M83.41%
2000-12-31C$9.17 M369.09%
1999-12-31C$1.95 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
C$89.76 B 3,238,213.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$65.39 B 2,359,046.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C$40.61 M 1,365.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$0.23 B 8,514.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$2.68 M-3.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C$13.21 M 376.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.93 B 33,594.11%๐Ÿ‡บ๐Ÿ‡ธ USA